In Vivo Disease Models
With more than 150 validated animal models (rat and mouse), our catalog boasts wide therapeutic coverage from across 14 therapeutic areas. We also offer custom models, modifications to our existing models, and can even help you replicate models from the literature.
Explore our models or contact us for custom options.
Phenotypic screening uncovers otherwise
unpredicted new uses for a drug
In Vivo Services
We offer access to dozens of animal models of human disease. Our commitment to in vivo services since 2005 has made us a CRO of choice for hundreds of companies.
In Vivo Pharmacology Platforms
The theraTRACE® and opioidTRACE® platforms are our phenotypic screening tools for drug repositioning, drug repurposing, and indications discovery.
About Melior
More than just a provider of in vivo pharmacology services, Melior is a pioneer of in vivo phenotypic screening and a leader in the area of drug repositioning.
Its proprietary theraTRACE® platform enables rapid and
cost-effective identification of new therapeutic potential
by systematically screening candidates in a diverse array
of validated in vivo disease models.
Serving the pharma industry since 2005
Thousands of completed studies
Hundreds of compounds evaluated
Dozens of animal models of human disease
“Melior provided State-of-the-art Preclinical Pharmacology Support for a period of nearly a year where a series of in vivo studies were completed on a weekly basis. The staff was extremely user-friendly, and the operational processes were excellent. I can recommend Melior without reservation.”
Richard DiMarchi, PhD
Indiana University, Department of Chemistry
Featured Case Studies
Browse our recent case studies from our collaborative discovery projects.
Recent Studies using Phenotypic Screening
Increasingly, phenotypic screening is being recognized as the best strategy to uncover otherwise unpredicted new uses of therapeutics.
Featured Publications
Browse our recent peer-reviewed publications from our collaborative discovery projects.